Drugs in Dev.
Immunology
Undisclosed
India 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tocilizumab,Methotrexate
Therapeutic Area : Immunology
Study Phase : Undisclosed
Sponsor : Theramex
Deal Size : Undisclosed
Deal Type : Agreement
Details : Theramex has entered into an agreement with Enzene Biosciences to develop, register and commercialise a biosimilar drug of Roche’s reference medicine RoActemra® (Tocilizumab). Tocilizumab will be available in parenteral vials, subcutaneous prefilled s...
Product Name : RoActemra-Generic
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
December 23, 2021
Lead Product(s) : Tocilizumab,Methotrexate
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Sponsor : Theramex
Deal Size : Undisclosed
Deal Type : Agreement
